EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Construction and validation of an ACTA2-based prognostic scoring model for colorectal adenocarcinoma

Xiao Che, Wenwei Huang, Yao Ying, Yuzhen Zhu, Yang Yang, Ke Mo, Xueqiong Han, Chunhui Cui, Lu Zhou

Translational Oncology · 2025-12 · 62 · 102530

DOI: 10.1016/j.tranon.2025.102530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Oncology, 2025-12. Verfasst von Xiao Che und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China; Department of Abdominal Hernia Surgery, Maomi…. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Guangxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to construct and validate a clinical scoring model for colorectal adenocarcinoma (COAD) based on ACTA2 to identify novel biomarkers. COAD-related data were obtained from the TCGA database, and the expression of ACTA2 was verified by in vitro experiments. WGCNA analysis was used to explore the biological processes associated with ACTA2. The results showed that ACTA2 was downregulated in COAD tissues, but its high expression was significantly associated with poor prognosis in patients. ACTA2 was closely related to immune cell infiltration, immune checkpoint genes, and tertiary lymphoid structure marker genes. In addition, there was a negative correlation between the methylation level and transcriptional level of ACTA2. The ACTA2-based clinical scoring model constructed in this study may serve as a novel biomarker for COAD, providing new insights for improving patient prognosis.

Schlagwörter

Stichwörter der Autor:innen

ACTA2ACTA2-based clinical scoring modelCOADWGCNA

Autor:innen und Institutionen

  • Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China; Department of Abdominal Hernia Surgery, Maoming People's Hospital, Southern Medical University, Maoming 525000, Chi…
  • Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China; Department of General Surgery, Foshan Maternal and Child Healthcare Hospital, Foshan 528000, China.
  • Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
  • School of Information and Management, Guangxi Medical University, Nanning, Guangxi 530021, China.
  • Department of Oncology, Xianhu Campus of the First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine, Nanning 530000, China.
  • Department of General Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China; Department of Intelligent Exploration for Drug Innovation Research, YuanDong International Academy Of Life Sciences…

Förderung

  • Natural Science Foundation of Guangxi Province

Zitieren

APA

Che, X., Huang, W., Ying, Y., Zhu, Y., Yang, Y., Mo, K., Han, X., Cui, C., & Zhou, L. (2025). Construction and validation of an ACTA2-based prognostic scoring model for colorectal adenocarcinoma. Translational Oncology, 62, 102530. https://doi.org/10.1016/j.tranon.2025.102530

Vancouver

Che X, Huang W, Ying Y, Zhu Y, Yang Y, Mo K, et al. Construction and validation of an ACTA2-based prognostic scoring model for colorectal adenocarcinoma. Translational Oncology. 2025;62:102530. doi:10.1016/j.tranon.2025.102530

BibTeX
@article{Che2025,
  author = {Che, Xiao and Huang, Wenwei and Ying, Yao and Zhu, Yuzhen and Yang, Yang and Mo, Ke and Han, Xueqiong and Cui, Chunhui and Zhou, Lu},
  title = {Construction and validation of an ACTA2-based prognostic scoring model for colorectal adenocarcinoma},
  journal = {Translational Oncology},
  year = {2025},
  volume = {62},
  pages = {102530},
  doi = {10.1016/j.tranon.2025.102530}
}
Kostenlos starten →